Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 5-Oil prices close to 13-month highs, supported by Texas cold snap

Tue, 16th Feb 2021 11:32

* Texas cold snap shuts down oil wells and refineries

* Middle East supply worries raised by Yemen conflict

* Norwegian oil terminal wage dispute resolved
(Updates prices, adds UBS price forecast)

By Shadia Nasralla

LONDON, Feb 16 (Reuters) - Oil prices hovered near 13-month
highs on Tuesday, supported by a U.S. cold snap that shut wells
in the oil-producing state of Texas, though gains were capped by
a Norwegian wage deal that averted supply disruptions in Europe.

The global rollout of coronavirus vaccinations, fuelling
expectations of a recovery in the global economy and oil demand,
has also kept prices buoyant.

Keenly watched U.S. oil inventory data from the API industry
association and Energy Information Administration (EIA) will be
released this week on Wednesday and Thursday respectively, each
delayed by a day after U.S. markets were closed for a public
holiday on Monday.

Benchmark Brent crude slipped 37 cents, or 0.5%, to
$62.93 a barrel by 1434 GMT but remained 13-month peak reached
in the previous session.

U.S. West Texas Intermediate (WTI) crude futures
gained 45 cents, or 0.8%, to $59.92 after touching their highest
since early January last year.

Swiss bank UBS increased its Brent price forecast, saying it
expects the benchmark to reach $68 a barrel in the second half
of the year and $70 by March 2022, with WTI trading at a $3
discount.

Cold weather in the United States halted operations at Texas
oil wells and refineries on Monday and forced restrictions on
natural gas and crude pipeline operators.

Texas produces about 4.6 million barrels per day of oil and
is home to 31 refineries, the most of any U.S. state and
including some of the country's largest, EIA data shows.

Middle East supply concerns also rose after the Saudi-led
coalition fighting the Houthi group in Yemen said on Monday that
it had destroyed an explosive-laden drone fired by the Houthis
at the kingdom, the world's biggest oil exporter.

But in a move that helped to cap prices, Norway's oil
industry employers struck a wage deal with the Safe labour union
on Tuesday, preventing a strike at the Mongstad crude terminal,
which could have forced major offshore oil and gas fields to
shut.

(Additional reporting by Jessica Jaganathan in Singapore
Editing by Edmund Blair and David Goodman
)

More News
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.